D-penicillamine therapy in AB0 hemolytic
✍
L. Lakatos; B. Kövér; Gy. Oroszlán; Zsuzsa Vekerdy
📂
Article
📅
1976
🏛
Springer
🌐
English
⚖ 276 KB
This study comprises 120 full-term infants with ABO hemolytic disease admitted to the neonatal department during a period of 60 months from 1970-1975. During the first 30 months newborns (n = 61) received no D-penicillamine therapy, whereas all infants (n = 59) received this treatment (300-400 mg/kg